NCT Number: NCT05519449
Phase: Phase 1
Trial Summary: This study is a first-in-human, Phase 1, open-label, multicenter study to assess the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Janux Therapeutics
Acronym:
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives